2015 Pancreatic Diseases Gordon Research Conference
2015 Pancreatic Diseases Gordon Research Conference
批准号:
8970783
负责人:
DIANE M SIMEONE
金额:
$1.5万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-06-19 至 2016-05-31
关键词:
Acinar CellAddressAreaBasic ScienceBeta CellBiologicalBiologyCellsChemicalsChemistryClinical ResearchCollaborationsCommunitiesComplexDevelopmentDiabetes MellitusDigestionDisciplineDiseaseDoctor of PhilosophyDuctal Epithelial CellDuodenumEmbryoEndocrineEndocrine System DiseasesEndocrinologistEnzymesEpidemiologyExocrine pancreasFoodFosteringFutureGastroenterologistGlandGlucagonGlucoseGoalsHealthHomeostasisHormonesHumanHuman bodyInsulinInternationalIslets of LangerhansLeadLifeMaintenanceMalignant NeoplasmsMalignant neoplasm of pancreasMedicalMedicineMentorshipMetabolicMusNatural regenerationOrganogenesisPancreasPancreatic AdenocarcinomaPancreatic DiseasesPancreatitisPharmacologyPhysiciansPhysiologicalPostdoctoral FellowProductionProtocols documentationQualifyingResearchResearch PersonnelRisk FactorsScientistSignal PathwaySocietiesSomatostatinSourceStructure of beta Cell of isletStudentsSurgeonTherapeuticTrainingTranslational ResearchTranslationsWorkbasecareercell typechronic pancreatitiscollegeinduced pluripotent stem cellinterdisciplinary approachinterestnovelnovel strategiespancreatic juicepostersprogramspublic health relevanceregenerative therapysocialstemsuccesssymposiumtransdifferentiation
中文摘要
描述(由申请人提供):
这个GRC的独特概念是汇集基础和医生科学家在胰腺疾病的各个方面,包括糖尿病,胰腺癌和胰腺炎的研究前沿。这些复杂的疾病对人类健康和社会构成了重大威胁,要想进一步了解和治疗这些疾病,就需要采取跨学科的方法。鉴于胰腺外分泌和内分泌细胞的密切发育和生理相关性以及胰腺癌和糖尿病之间的重要流行病学关联,特别认为这些领域的领导者之间的科学交流论坛提供了一个独特的机会,以建立新的合作,并促进这些研究领域急需的进展,并将这些信息转化为医疗实践。因此,该GRC的一个具体目标是通过两年一次的聚会创建和巩固一个有凝聚力的研究社区,包括医学,生物学,化学和药理学专家,致力于胰腺的研究及其相关疾病的治疗。继第一次会议的成功,第二次GRC“胰腺疾病”将于2015年7月19日至24日在美国马萨诸塞州南哈德利的霍利奥克山学院举行。该计划已经组装是一流的,受益于国际世界级科学家的贡献,从事研究相关的胰腺疾病的不同方面。会议的最终目标是确定胰腺疾病的新概念,这些新概念可能可用于药理学和基于细胞的治疗方法。对于所有GRCs,本次会议的指导原则是介绍新的、未发表的结果,以及随后进行的自由、不受阻碍的讨论。特别欢迎年轻科学家,包括博士生,博士后和初级小组领导人的参与,并提供简短的演讲和海报展示的机会。
英文摘要
DESCRIPTION (provided by applicant):
The distinctive concept of this GRC is to bring together basic and physician scientists at the forefront of research in all aspects of pancreatic diseases, including diabetes, pancreatic cancer and pancreatitis. These complex diseases represent a major threat for human health and society and advancement in their understanding and treatment requires an interdisciplinary approach. Given the close developmental and physiological relatedness of pancreatic exocrine and endocrine cells and the significant epidemiological association between pancreatic cancer and diabetes, it is especially felt that a forum for scientific exchange among leaders in these fields provides a unique opportunity to establish new collaborations and foster much needed progress in these research areas and translation of this information into medical practice. Accordingly, a specific objective of this GRC is the creation and consolidation through its biennial gathering of a cohesive research community including experts in medicine, biology, chemistry and pharmacology dedicated to the study of the pancreas and the cure of its related disorders. Following the success of the first conference, the second GRC "Pancreatic Diseases" will take place July 19- 24, 2015 at Mount Holyoke College South Hadley, MA, USA. The program that has been assembled is first- rate, benefitting from the contribution of international world-class scientists engaged in research relevant to different aspects of pancreatic diseases. The ultimate goal of the conference is the identification of novel concepts in pancreatic diseases that might be exploitable for pharmacological and cell-based therapeutic approaches. As for all GRCs, the guiding principle of this Conference is the presentation of new, unpublished results and the free, unhampered discussion that follows. Participation of young scientists, including PhD students, postdocs and junior group leaders is especially welcome, with opportunities of short talks and poster presentations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biomarker Validation in Pancreatic Cystic Neoplasms
-
批准号:10722347
-
项目类别:
-
资助金额:$89.83万
-
财政年份:2023
-
负责人:DIANE M SIMEONE
-
依托单位:
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma
-
批准号:10218126
-
项目类别:
-
资助金额:$69.03万
-
财政年份:2020
-
负责人:DIANE M SIMEONE
-
依托单位:
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma
-
批准号:10442427
-
项目类别:
-
资助金额:$66.65万
-
财政年份:2020
-
负责人:DIANE M SIMEONE
-
依托单位:
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma
-
批准号:10656484
-
项目类别:
-
资助金额:$65.62万
-
财政年份:2020
-
负责人:DIANE M SIMEONE
-
依托单位:
Oncogenic Function of ATDC in Bladder Cancer
-
批准号:9491077
-
项目类别:
-
资助金额:$48.58万
-
财政年份:2014
-
负责人:DIANE M SIMEONE
-
依托单位:
Oncogenic Function of ATDC in Bladder Cancer
-
批准号:9017959
-
项目类别:
-
资助金额:$44.43万
-
财政年份:2014
-
负责人:DIANE M SIMEONE
-
依托单位:
Project 3: lncRNA SNHG1 and ATG7 in Basal-subtype Muscle-invasive Bladder Tumorigenesis
-
批准号:10661067
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2013
-
负责人:DIANE M SIMEONE
-
依托单位:
Project 3: lncRNA SNHG1 and ATG7 in Basal-subtype Muscle-invasive Bladder Tumorigenesis
-
批准号:10229414
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2013
-
负责人:DIANE M SIMEONE
-
依托单位:
Project 3: lncRNA SNHG1 and ATG7 in Basal-subtype Muscle-invasive Bladder Tumorigenesis
-
批准号:10455731
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2013
-
负责人:DIANE M SIMEONE
-
依托单位:
P4 - ATDC as a Therapeutic Target in Pancreatic Cancer
-
批准号:7893337
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2010
-
负责人:DIANE M SIMEONE
-
依托单位:
ATDC Function in Human Pancreatic Adenocarcinoma
-
批准号:9041530
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2008
-
负责人:DIANE M SIMEONE
-
依托单位:
ATDC Function in Human Pancreatic Adenocarcinoma
-
批准号:7920797
-
项目类别:
-
资助金额:$31.82万
-
财政年份:2008
-
负责人:DIANE M SIMEONE
-
依托单位:
Early Detection Biomarkers in Pancreatic Adenocarcinoma
-
批准号:9490986
-
项目类别:
-
资助金额:$40.26万
-
财政年份:2008
-
负责人:DIANE M SIMEONE
-
依托单位:
ATDC Function in Human Pancreatic Adenocarcinoma
-
批准号:8130938
-
项目类别:
-
资助金额:$30.86万
-
财政年份:2008
-
负责人:DIANE M SIMEONE
-
依托单位:
ATDC Function in Human Pancreatic Adenocarcinoma
-
批准号:7683863
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2008
-
负责人:DIANE M SIMEONE
-
依托单位:
ATDC Function in Human Pancreatic Adenocarcinoma
-
批准号:8881830
-
项目类别:
-
资助金额:$36.84万
-
财政年份:2008
-
负责人:DIANE M SIMEONE
-
依托单位:
ATDC Function in Human Pancreatic Adenocarcinoma
-
批准号:7529936
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2008
-
负责人:DIANE M SIMEONE
-
依托单位:
Studies of Pancreatic TGFBeta-Mediated Signaling
-
批准号:7046705
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2003
-
负责人:DIANE M SIMEONE
-
依托单位:
Surgical Study of Pancreatic TGFBeta-Mediated Signaling
-
批准号:6611663
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2003
-
负责人:DIANE M SIMEONE
-
依托单位:
Studies of Pancreatic TGFBeta-Mediated Signaling
-
批准号:6874303
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2003
-
负责人:DIANE M SIMEONE
-
依托单位:
海外基金